Main elements from their results :
- large improvement of their gross margin during H2 (from 43.9 % during H2 22 to 44.7 % during H2 23) vs - 3 % for their sales during H2, which shows that they focus on profitability,
- cash flow from operation increased by 14 % vs + 2 % for EBITDA, so a large part of cash flow increase comes from the improvement of working capital (inventory, but expected to reverse in FY 24).
Once again, Shaver Shop is showing the strong resistance of its earnings, while it has a free cash flow yield of 12 %.
- Forums
- ASX - By Stock
- SSG
- Ann: SSG - Appendix 4E & Consolidated Financial Report
Ann: SSG - Appendix 4E & Consolidated Financial Report, page-6
-
- There are more pages in this discussion • 107 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SSG (ASX) to my watchlist
|
|||||
Last
$1.17 |
Change
0.000(0.00%) |
Mkt cap ! $153.2M |
Open | High | Low | Value | Volume |
$1.17 | $1.17 | $1.16 | $24.25K | 20.78K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 20796 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 1992 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 20796 | 1.160 |
3 | 26466 | 1.155 |
6 | 49909 | 1.150 |
1 | 2200 | 1.145 |
4 | 50364 | 1.140 |
Price($) | Vol. | No. |
---|---|---|
1.170 | 1992 | 3 |
1.180 | 93879 | 4 |
1.195 | 49147 | 2 |
1.200 | 48509 | 6 |
1.210 | 39701 | 2 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
SSG (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online